close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar2Point66
Implied share price

Buy Undervalued by 478.3%

5% margin of safety What's this?

EV / EBITDA
Use Average
SIP
Sigma Pharmaceutical Limited
DNA
Genentech, Inc.
Change
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
CELG
Celgene Corporation
Change
13.98 3.28 17.08 7.42 7.68 22.76
All amounts in millions
from last financial year
         
Implied Share Price $2.66 $78.32 $100.12 $60.29 $35.78
Market Cap 542 100,042 52,217 29,714 24,978
Net Debt 253 -3,369 -2,841 -495 -2,975
Enterprise Value (EV) 795 96,673 49,376 29,218 22,003
Revenue 3,220 13,418 14,642 7,011 2,689
EBITDA 242 5,661 6,658 3,802 966
Percent 7.5 % 42.2 % 45.5 % 54.2 % 35.9 %
EBIT 196 5,069 5,609 3,589 841
Percent 6.1 % 37.8 % 38.3 % 51.2 % 31.3 %
Balance Sheet          
Total Assets 1,926 21,787 39,629 9,698 5,389
Total Liabilities 859 6,116 16,962 3,331 994
Shareholders Equity 1,066 15,671 22,667 6,367 4,394.606

Comments

No comments yet. Login to comment.